265 related articles for article (PubMed ID: 22470853)
1. Vasopressin receptor antagonists and their role in clinical medicine.
Narayen G; Mandal SN
Indian J Endocrinol Metab; 2012 Mar; 16(2):183-91. PubMed ID: 22470853
[TBL] [Abstract][Full Text] [Related]
2. Clinical review: the use of vaptans in clinical endocrinology.
Peri A
J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044
[TBL] [Abstract][Full Text] [Related]
3. [Vasopressin antagonists in treatment of hyponatremia].
Olszewski W; Głuszek J
Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
[TBL] [Abstract][Full Text] [Related]
4. Role of vaptans in the management of hyponatremia.
Lehrich RW; Ortiz-Melo DI; Patel MB; Greenberg A
Am J Kidney Dis; 2013 Aug; 62(2):364-76. PubMed ID: 23725974
[TBL] [Abstract][Full Text] [Related]
5. [Vasopressin receptor antagonists: the vaptans].
Villabona C
Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
[TBL] [Abstract][Full Text] [Related]
6. Vaptans for the treatment of hyponatremia.
Robertson GL
Nat Rev Endocrinol; 2011 Mar; 7(3):151-61. PubMed ID: 21283124
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients.
Nodari S; Jao GT; Chiong JR
Int J Nephrol Renovasc Dis; 2010; 3():51-60. PubMed ID: 21694929
[TBL] [Abstract][Full Text] [Related]
8. Conivaptan: Evidence supporting its therapeutic use in hyponatremia.
Li-Ng M; Verbalis JG
Core Evid; 2010 Jun; 4():83-92. PubMed ID: 20694067
[TBL] [Abstract][Full Text] [Related]
9. Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells.
Di Mise A; Venneri M; Ranieri M; Centrone M; Pellegrini L; Tamma G; Valenti G
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888044
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal Syndrome: Role of Arginine Vasopressin and Vaptans in Heart Failure.
Vinod P; Krishnappa V; Chauvin AM; Khare A; Raina R
Cardiol Res; 2017 Jun; 8(3):87-95. PubMed ID: 28725324
[TBL] [Abstract][Full Text] [Related]
11. Vaptans: A new option in the management of hyponatremia.
Aditya S; Rattan A
Int J Appl Basic Med Res; 2012 Jul; 2(2):77-83. PubMed ID: 23776817
[TBL] [Abstract][Full Text] [Related]
12. Conivaptan and its role in the treatment of hyponatremia.
Ghali JK; Farah JO; Daifallah S; Zabalawi HA; Zmily HD
Drug Des Devel Ther; 2009 Dec; 3():253-68. PubMed ID: 20054444
[TBL] [Abstract][Full Text] [Related]
13. Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
Gross PA; Wagner A; Decaux G
Kidney Int; 2011 Sep; 80(6):594-600. PubMed ID: 21451459
[TBL] [Abstract][Full Text] [Related]
14. [Etiology, diagnostics and therapy of hyponatremias].
Laczi F
Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
[TBL] [Abstract][Full Text] [Related]
15. Hyponatremia in Heart Failure: Pathogenesis and Management.
Rodriguez M; Hernandez M; Cheungpasitporn W; Kashani KB; Riaz I; Rangaswami J; Herzog E; Guglin M; Krittanawong C
Curr Cardiol Rev; 2019; 15(4):252-261. PubMed ID: 30843491
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms, risks, and new treatment options for hyponatremia.
Ghali JK
Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
Farmakis D; Filippatos G; Kremastinos DT; Gheorghiade M
Curr Heart Fail Rep; 2008 Jun; 5(2):91-6. PubMed ID: 18765079
[TBL] [Abstract][Full Text] [Related]
18. [Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Dabrowska MD; Krysiak R; Okopień B
Wiad Lek; 2012; 65(1):19-30. PubMed ID: 22827112
[TBL] [Abstract][Full Text] [Related]
19. Unpredictable nature of tolvaptan in treatment of hypervolemic hyponatremia: case review on role of vaptans.
Malhotra I; Gopinath S; Janga KC; Greenberg S; Sharma SK; Tarkovsky R
Case Rep Endocrinol; 2014; 2014():807054. PubMed ID: 24511399
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hyponatremia: the role of lixivaptan.
Liamis G; Filippatos TD; Elisaf MS
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):431-41. PubMed ID: 24766294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
